Bis(2-Ethylhexyl)-2,3,4,5-Tetrabromophthalate Promotes NASH Progression through Disrupting Endoplasmic
Yuxi Zhou1, Bingjie Li1,2, Jiadi Zhao3
1Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan 430072, China.
Bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate (TBPH) exposure worsens nonalcoholic steatohepatitis (NASH) by disrupting lipid metabolism and mitochondrial function. Activating Mitofusin2 (MFN2) in liver organoids reversed these harmful effects, suggesting TBPH as a NASH risk factor.
Area of Science:
- Environmental Health
- Hepatology
- Toxicology
Background:
- Environmental pollutants are linked to chronic liver diseases.
- Bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate (TBPH), a brominated flame retardant, is detected in human tissues, but its liver disease role is unclear.
Purpose of the Study:
- To investigate the impact of TBPH exposure on nonalcoholic steatohepatitis (NASH) progression and mechanisms using mouse and liver organoid (LO) models.
Main Methods:
- Diet-induced NASH mouse model and liver organoid (LO) model.
- Lipidomic analysis to identify metabolic changes.
- Investigation of Mitofusin2 (MFN2) expression and endoplasmic reticulum-mitochondria (ER-Mito) contacts.
- Treatment with MFN2 agonist M1 in LOs.
Main Results:
- TBPH exposure exacerbated hepatic steatosis, inflammation, and fibrosis in mice.
- TBPH disrupted phospholipid metabolism, reducing cardiolipin (CL) and phosphatidylserine (PS).
- TBPH decreased MFN2, impairing ER-Mito contacts, phospholipid transfer, and mitochondrial function, triggering UPRmt and ER stress.
- MFN2 activation in LOs ameliorated TBPH-induced NASH phenotypes by restoring ER-Mito contacts and bioenergetics.
Conclusions:
- TBPH is identified as an environmental risk factor contributing to NASH progression.
- The study highlights the critical role of MFN2-mediated ER-Mito contacts in lipid metabolism and liver health.
- Findings offer new perspectives for evaluating the health risks associated with brominated flame retardants.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
07:22Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
